August 22, 2017

Can Big Data Help Us Create a Medical Test for Autism?

By Kayla Matthews

Big Data and Autism

Many mysteries surround autism spectrum disorder. Arguably, one of the largest is how to authoritatively diagnose it in children. However, scientists have developed the first physiological test, based on a big data algorithm. Keep reading to learn more about this advancement and what it might mean for society at large.

Specifics About the Discovery

Scientists from Rensselaer Polytechnic Institute started by looking at metabolites — the products of metabolic reactions catalyzed by enzymes. After evaluating 24 metabolites within a blood sample, scientists used big data-driven technologies to find similarities between that blood component and cellular pathways with a suspected link to autism.

The ability to do this was significant because big data capabilities allowed scientists to scrutinize the metabolites together instead of separately when looking for patterns. In addition to being able to tell if a person is on the autism spectrum, the blood test can, to a certain degree, identify where on the spectrum that individual falls.

Although other scientists have looked at individual metabolites to pinpoint how they relate to autism, those results have not been conclusive, or easy to replicate in other studies. Because scientists could use big data to look at numerous metabolites simultaneously, their outcomes became statistically stronger.

The Impact on the Medical Community and the World

Members of the medical sector who perform research in laboratories know the tasks they do are very precise, and that seemingly small factors could make big differences in overall results. For example, blood specimen tubes spun in a horizontal centrifuge produce more plasma or serum for analysis, compared to Containers characterized by a fixed-angle centrifuge.

Because big data allows people in the scientific community to look at huge samples of data, it increases scientists’ ability to figure out how smaller factors cause certain results in the overall findings of particular studies. Big data might be instrumental in aiding scientists to improve the aforementioned metabolite test, making it even more reliable than previously thought.

This recent news is far from the first attempt to determine autism risk through blood-work. Doctors are already using genetic tests to help screen for autism, comparing individual DNA with a genome marker contained on a chip. Data says more than 60 percent of parents who received genetic testing results with insight into whether a child might be autistic found them at least somewhat helpful.

Although most parents were glad to know what the test revealed, some were also frustrated because the results were not always informative or immediately helpful. If the big data metabolite test continues to give strong results in the lab, it could be seen as the new standard used when parents want to know more about potential autism risks.

Information from the CDC released before the breaking news about this emerging blood test cautioned there is a two-part screening process for detecting autism. By the time a child reaches his second birthday, the diagnosis of autism is much more reliable than it is earlier in life. However, many kids don’t get final opinions about diagnoses until they are much older, delaying essential treatments that could improve the quality of their lives.

Theoretically, the big data blood test you’ve learned about could cut down on or eliminate those slowed responses. Then, parents have more peace of mind and their sons and daughters have faster access to treatment.

Studies carried out with data collected from the United States and the United Kingdom found that lifetime care costs for a person with autism can be $2 million or more. If this new big data test is consistently more efficient at reaching firm conclusions about whether a patient has autism, some of those expenses might decrease, especially if parents can make well-informed decisions sooner.

Although ongoing experimentation is still necessary for the big data blood test, the results so far are promising. In coming years, we might screen for autism in improved, more dependable ways, because of what this research revealed.

By Kayla Matthews

Kayla Matthews

Kayla Matthews is a technology writer dedicated to exploring issues related to the Cloud, Cybersecurity, IoT and the use of tech in daily life.

Her work can be seen on such sites as The Huffington Post, MakeUseOf, and VMBlog. You can read more from Kayla on her personal website.
Cloud Computing Humor

5 Cloud-Based Documentation Tools Compared

Documentation Tools Compared What Are Cloud-Based Documentation Tools? Cloud-based documentation tools are software platforms that [...]
Read more
Stacey Farrar

Six Things to Consider When Choosing Between Free and Paid Migration Tools

Choosing Between Free and Paid Migration Tools Microsoft recently decided to stop offering its free [...]
Read more

Leading Container Security Services for Cloud-Native Environments

Leading Container Security Services In today’s rapidly evolving digital landscape, container security has become a [...]
Read more
Bright Data

10 Leading Proxy Services: Enhancing Your Online Security and Privacy

10 Leading Proxy Services In the realm of digital technology, proxies emerge as critical tools, [...]
Read more

The Competitive Edge: Leveraging AI Assistant Sales Tools for Market Dominance

Leading AI Sales Assistant Tools As we navigate the ever-evolving landscape of sales technology, AI [...]
Read more
Drew Firment

Future Unveiled: Q&A with Drew Firment on AI, Cloud, & Beyond

AI, Cloud, & Beyond As we delve into the realm where artificial intelligence intersects with [...]
Read more

SPONSOR PARTNER

Unlock the power of Google Cloud with a $350 signup credit. Experience enhanced scalability, security, and innovation for your projects today!
© 2024 CloudTweaks. All rights reserved.